Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05873686 |
| Title | A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Nuvectis Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mayo Clinic | RECRUITING | Phoenix | Arizona | 85054 | United States | Details |
| Sarah Cannon Research Institute at HealthONE | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Mayo Clinic | RECRUITING | Jacksonville | Florida | 32224 | United States | Details |
| Oregon Health and Science University | RECRUITING | Portland | Oregon | 97239 | United States | Details |
| The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
| Ward 1 - Edinburgh Cancer Centre, Western General Hospital | RECRUITING | Edinburgh | EH4 2XU | United Kingdom | Details | |
| The Royal Marsden NHS Foundation and Trust | RECRUITING | London | SW3 6JJ | United Kingdom | Details |